Stay updated on Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-08T13:42:23.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the study details that were previously visible on the page.
    Difference
    18%
    Check dated 2026-09-24T18:55:28.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The release notes now display Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating a new deployment of the page. This is a metadata/version update rather than a substantive modification to the study details.
    Difference
    0.0%
    Check dated 2026-09-17T22:07:49.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing the previous v3.6.5. This is a software version update and does not alter the displayed study information.
    Difference
    0.0%
    Check dated 2026-09-03T19:01:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new funding identifier, 2023 ( U.S. NIH Grant/Contract ), was added under Other Study ID Numbers, signaling NIH support for the study.
    Difference
    0.0%
    Check dated 2026-08-27T18:09:00.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's release notes show a new revision label (v3.6.5) replacing the previous v3.6.4, indicating a minor update to the page/system rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-06T19:27:25.000Z thumbnail image

Stay in the know with updates to Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.